The WACC of Heron Therapeutics Inc (HRTX) is 7.6%.
| Range | Selected | |
| Cost of equity | 7.80% - 11.10% | 9.45% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.30% - 7.00% | 6.15% |
| WACC | 6.3% - 8.8% | 7.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.85 | 1.12 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.80% | 11.10% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.61 | 0.61 |
| Cost of debt | 5.30% | 7.00% |
| After-tax WACC | 6.3% | 8.8% |
| Selected WACC | 7.6% | |